Sugar chains of serum transferrin from patients with carbohydrate deficient glycoprotein syndrome. Evidence of asparagine-N-linked oligosaccharide transfer deficiency
- PMID: 8449944
Sugar chains of serum transferrin from patients with carbohydrate deficient glycoprotein syndrome. Evidence of asparagine-N-linked oligosaccharide transfer deficiency
Abstract
The structure of over 93% of the sugar chains of serum transferrin purified from three patients with carbohydrate-deficient glycoprotein (CDG) syndrome was Neu5Ac alpha 2-->6Gal beta 1-->4GlcNAc beta 1-->2Man alpha 1-->6 (Neu5Ac alpha 2-->6Gal beta 1-->4GlcNAc beta 1-->2Man alpha 1-->3)Man beta 1-->4GlcNac beta 1-->4GlcNAc, similar to that in a healthy control. On chromatofocusing, CDG syndrome transferrin was separated into three major isoforms, S4, S2, and S0, containing 4, 2, and 0 sialic acids/molecule at pH 5.12 (5.16), 5.42, and 5.80, respectively. On 7.5% SDS-polyacrylamide gel electrophoresis, the molecular masses of transferrin isoforms S4, S2, and S0 were 80, 77, and 74 kDa, respectively. Transferrin isoforms S4 and S2 were linked to 2 and 1 mol of sialylated biantennary sugar chain/transferrin molecule, on the other hand, isoform S0 was not linked to any asparagine-N-linked oligosaccharide. Accordingly, CDG syndrome can be concluded to be an asparagine-N-linked oligosaccharide transfer deficiency, although the primary deficient enzyme has not yet been determined.
Similar articles
-
Electrospray ionization-mass spectrometric analysis of serum transferrin isoforms in patients with carbohydrate-deficient glycoprotein syndrome.J Biochem. 1993 Dec;114(6):766-9. doi: 10.1093/oxfordjournals.jbchem.a124253. J Biochem. 1993. PMID: 8138529
-
Sugar chains of human cord serum alpha-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas.Cancer Res. 1993 Jul 1;53(13):2970-5. Cancer Res. 1993. PMID: 7686446
-
Alteration of asparagine-linked glycosylation in serum transferrin of patients with hepatocellular carcinoma.Clin Chim Acta. 1994 Jan 14;224(1):1-8. doi: 10.1016/0009-8981(94)90115-5. Clin Chim Acta. 1994. PMID: 8174273
-
The carbohydrate-deficient glycoprotein syndromes: pre-Golgi and Golgi disorders?Glycobiology. 1993 Oct;3(5):423-8. doi: 10.1093/glycob/3.5.423. Glycobiology. 1993. PMID: 8286854 Review.
-
Analysis of asparagine-linked oligosaccharides by sequential lectin-affinity chromatography.Methods Mol Biol. 1993;14:17-34. doi: 10.1385/0-89603-226-4:17. Methods Mol Biol. 1993. PMID: 8348233 Review.
Cited by
-
Lectin-Based Approaches to Analyze the Role of Glycans and Their Clinical Application in Disease.Int J Mol Sci. 2024 Sep 23;25(18):10231. doi: 10.3390/ijms251810231. Int J Mol Sci. 2024. PMID: 39337716 Free PMC article. Review.
-
Carbohydrate deficient glycoprotein (CDG) syndrome type I.J Med Genet. 1997 Jan;34(1):73-6. doi: 10.1136/jmg.34.1.73. J Med Genet. 1997. PMID: 9032653 Free PMC article. No abstract available.
-
Congenital disorders of glycosylation type I leads to altered processing of N-linked glycans, as well as underglycosylation.Biochem J. 2001 Oct 15;359(Pt 2):249-54. doi: 10.1042/0264-6021:3590249. Biochem J. 2001. PMID: 11583570 Free PMC article.
-
Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie).J Clin Invest. 2000 Jan;105(2):191-8. doi: 10.1172/JCI7302. J Clin Invest. 2000. PMID: 10642597 Free PMC article.
-
A retrospective and prospective view of glycopathology.Glycoconj J. 1998 Apr;15(4):323-31. doi: 10.1023/a:1006961532182. Glycoconj J. 1998. PMID: 9613818 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical